Total raised
$65.0M
Last stage
Series A
Investors
Raviv Pryluk
PhD in computational neuroscience from the Weizmann Institute. Spent 15+ years as a technology leader in defense and tech industries. Previously SVP of Operations and Analytics at Immunai before founding PhaseV in 2023.
LinkedInElad Berkman
BSc in physics from The Hebrew University (Talpiot program), M.Eng. in systems engineering from the Technion. Served eight years in defense industries, then led data science and algorithmic design at VIA for seven years before co-founding PhaseV.
Dan Goldstaub
Previously managed clinical trials at Teva and MSD (Merck). Also listed with a past role as COO at Tiltan Pharma per Crunchbase.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.